AXON Form 144: Proposed Sale of 5,000 Shares Valued $3.54M

AXON ENTERPRISE, INC.

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. Form 144 notice: The filer reports a proposed sale of 5,000 shares of Common stock through Morgan Stanley Smith Barney LLC on 09/29/2025, with an aggregate market value reported at $3,544,200.00 and a stated number of outstanding shares of 78,504,440. The securities were acquired as Restricted Stock Units on 09/26/2025 from the issuer and payment/consideration is listed as N/A. The filing also discloses a prior sale by Brittany Bagley of 870 shares on 09/15/2025 for gross proceeds of $672,724.89. Broker address and signature/attestation language are included in the notice.

Insights

Securities Analyst

TL;DR: Insider intends to sell 5,000 RSU-derived shares shortly after vesting; prior small sale of 870 shares recorded.

The Form 144 shows a planned brokered sale of 5,000 common shares valued at $3,544,200 on 09/29/2025, with the shares acquired as restricted stock units on 09/26/2025. The short interval between acquisition and proposed sale is documented factually in the filing. A separate sale by Brittany Bagley of 870 shares on 09/15/2025 produced $672,724.89 in gross proceeds. These items are disclosures of proposed and completed insider sales; the filing contains no forward-looking commentary or other financial metrics.

Corporate Governance Expert

TL;DR: Required insider sale notice submitted with broker details and seller attestation; no material disclosures beyond transaction data.

The Form 144 includes the broker (Morgan Stanley Smith Barney LLC) and the seller/beneficial-owner transaction history required under Rule 144. The filer attests to lacking undisclosed material adverse information. There is no additional corporate action, executive change, or financing described in the document; it is a routine notice of proposed sale and past sale activity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What securities does the AXON Form 144 propose to sell?

The notice proposes the sale of 5,000 shares of AXON common stock through Morgan Stanley Smith Barney LLC.

When were the shares to be sold and what is their reported aggregate value?

The proposed sale date is 09/29/2025 with an aggregate market value reported as $3,544,200.00.

How were the 5,000 shares acquired according to the filing?

The 5,000 shares were acquired as Restricted Stock Units on 09/26/2025 from the issuer.

Does the filing show any recent sales by the same person?

Yes. The filing discloses a prior sale by Brittany Bagley of 870 shares on 09/15/2025 for gross proceeds of $672,724.89.

Which broker is handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/29/2025 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001743490
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axon Enterprise, Inc.
SEC File Number	001-16391
Address of Issuer	17800 North 85th Street Scottsdale ARIZONA 85255
Phone	4809910797
Name of Person for Whose Account the Securities are To Be Sold	BRITTANY BAGLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	3544200.00	78504440	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/26/2025	Restricted Stock Units	Issuer			5000	09/26/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRITTANY BAGLEY 17800 North 85th Street Scottsdale AZ 85255	Common	09/15/2025	870	672724.89

144: Remarks and Signature

Remarks
Date of Notice	09/29/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brittany Bagley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)